Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0783 per EA under NDC 43547042403. Its NADAC has been published 402 times since Dec 12, 2018.

FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB

losartan potassium and hydrochlorothiazide
$0.0783per EA

Strength

25; 100 mg/1; mg/1

NDC

43547042403

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204901

FDA Approved

11/6/2017

TE Code

AB

On Market Since

2/15/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0783 per EA
All-time high$0.2811 (May 11, 2022)
All-time low$0.0771 (Jan 23, 2019)
52-week high$0.0876
52-week low$0.0771
Median price$0.1277
Average price$0.1335
Largest weekly change+41.4% (Jan 29, 2020)
Weeks tracked402
Tracking sinceDec 12, 2018

Price History

1W

+1.6%

1M

+1.6%

3M

-3.4%

6M

-3.5%

1Y

-7.6%

3Y

-37.2%

5Y

-54.5%

All

-2.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0783 per EA (NDC 43547042403), effective Aug 19, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 2.6%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

Since Dec 12, 2018, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0771 (Jan 23, 2019) to a high of $0.2811 (May 11, 2022), with a median of $0.1277 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 43547042403) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.